Ultrasound method for enhancing image presentation when contrast agents are used

• US 6,077,225 A
• Filed: 01/23/1998
• Issued: 06/20/2000
• Est. Priority Date: 01/23/1998
• Status: Expired due to Fees

• Current Assignee: Koninklijke Philips N.V.
• Original Assignee: Hewlett-Packard Company (HP Inc.)
• Inventors: Brock-Fisher, George A.
• Primary Examiner(s): Lateef, Marvin M.
• Assistant Examiner(s): Imam, Ali M.
• Application Number:
  US09/012,291
• Time in Patent Office: 879 Days
• Field of Search: 600/437, 600/439, 600/440, 600/441, 600/454, 600/458, 601/2
• US Class Current: 600/439
• CPC Class Codes: A61B 8/481 involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream analysis of echo signal exploiting properties of a contrast enhancer in devices for short-range imaging with acoustic waves G01S7/52039
• CPC Class Codes: G01S 7/52038 involving non-linear properties of the propagation medium or of the reflective target
• CPC Class Codes: G01S 7/52074 Composite displays, e.g. split-screen displays; Combination of multiple images or of images and alphanumeric tabular information

Abstract

Improved ultrasound images of a patient'"'"'s tissue region of interest (ROI) are achieved through the use of a contrast agent. The method includes the steps of: administering the contrast agent to the patient'"'"'s circulatory system; providing a user interface which enables a user to select a target region within the tissue ROI to be irradiated and to operate an ultrasound transducer to irradiate the selected target region with sufficient ultrasound energy to substantially reduce a backscatter effect of contrast agent that is present therein; and operating an ultrasound transducer to image the tissue ROI. It is preferred that the contrast agent be encapsulated into microbubbles The method is further applicable to selective destruction of encapsulated therapeutics which arrive at a tissue ROI to which the therapeutic is to be administered.

Claims

1. A method for providing improved ultrasound images of perfusion of a patient'"'"'s tissue region of interest (ROI) through use of a contrast agent, wherein said tissue ROI is positioned so that ultrasound reflections received by an imaging transducer are affected by an obscuring region that is perfused with said contrast agent, said method comprising the steps of:

a) administering said contrast agent to said patient'"'"'s circulatory system so that said contrast agent reaches both said obscuring region and said tissue ROI;

b) controlling said ultrasound transducer means to irradiate said contrast agent that enters said obscuring region, with sufficient ultrasound energy to substantially reduce an effect of said contrast agent upon ultrasound transmissions through said obscuring region; and

c) operating said ultrasound transducer means to image said tissue ROI.

2. The method as recited in claim 1, wherein said contrast agent is encapsulated and said ultrasound energy from said ultrasound transducer means is sufficiently strong to rupture structures which encapsulate said contrast agent.

3. The method as recited in claim 1, wherein said ultrasound means comprises a first ultrasound transducer and a second ultrasound transducer, and wherein step b) controls said first ultrasound transducer to image said tissue ROI and controls said second ultrasound transducer to provide sufficient radiation energy to reduce said effect of said contrast agent.

4. The method as recited in claim 3, wherein said second ultrasound means is controlled to position said radiation energy so as not to affect contrast agent which is present in said tissue ROI.

5. The method as recited in claim 4, wherein step c) operates, at nonsimultaneous times, said first ultrasound transducer to image said tissue ROI and said second ultrasound transducer to reduce said effect of said contrast agent, so as to enable observation of flow of said contrast agent into and through said tissue ROI.

6. The method as recited in claim 4, wherein said first ultrasound transducer images said tissue ROI using a first scan plane and said second ultrasound transducer provides said radiation energy in a second scan plane, wherein said second scan plane is non-coplanar with said first scan plane.

7. The method as recited in claim 2, wherein said tissue ROI includes a region of a patient'"'"'s heart muscle and said subregion is positioned to enable rupture of said encapsulated contrast agent as it enters a ventricle of said patient'"'"'s heart.

8. An ultrasound method for controlling administration of an encapsulated therapeutic agent to a patient'"'"'s tissue region of interest (ROI), said method comprising the steps of:

a) administering said encapsulated therapeutic agent to said patient so that said encapsulated therapeutic agent reaches said tissue ROI; and

b) operating imaging transducer means (i) to image said tissue ROI, and (ii) to radiate said encapsulated therapeutic agent only within a selected subregion of said tissue ROI that is imaged, with sufficient ultrasound energy to cause a release said therapeutic agent.

9. The ultrasound method as recited in claim 8, wherein said radiation from said ultrasound transducer means is sufficiently energetic to rupture structures which encapsulate said therapeutic agent.

10. The method as recited in claim 8, wherein said ultrasound means comprises a first ultrasound transducer and a second ultrasound transducer that are oriented so that beam patterns produced thereby intersect at said tissue ROI, and wherein step b) operates said first ultrasound transducer and said second ultrasound transducer to provide sufficient radiation energy to cause said release of said therapeutic agent only at a region of intersection of said beam patterns.

11. The method as recited in claim 8, wherein said ultrasound means comprises a first ultrasound transducer and a second ultrasound transducer, and wherein step b) operates said first ultrasound transducer to image said tissue ROI and operates said second ultrasound transducer to provide sufficient radiation energy to cause said release of said therapeutic agent.

12. The ultrasound method as recited in claim 8, wherein said encapsulated therapeutic agent also includes an ultrasound contrast enhancing agent.

13. An ultrasound apparatus for enabling control of administration of an encapsulated therapeutic agent to a patient'"'"'s tissue region of interest (ROI) when said encapsulated therapeutic agent reaches said tissue ROI, said ultrasound apparatus comprising:

a) means for operating transducer means to image said tissue ROI; and

b) means for controlling said transducer means to radiate said encapsulated therapeutic agent only within a selected subregion of said tissue ROI that is imaged, with sufficient ultrasound energy to cause a release said therapeutic agent.

14. The ultrasound apparatus as recited in claim 13, wherein said radiation from said ultrasound transducer means is sufficiently energetic to rupture structures which encapsulate said therapeutic agent.

15. The ultrasound apparatus as recited in claim 13, wherein said ultrasound means comprises a first ultrasound transducer and a second ultrasound transducer that are oriented so that beam patterns produced thereby intersect at said tissue ROI, and wherein means b) operates said first ultrasound transducer and said second ultrasound transducer to provide sufficient radiation energy to cause said release of said therapeutic agent only at a region of intersection of said beam patterns.

16. The ultrasound apparatus as recited in claim 13, wherein said ultrasound means comprises a first ultrasound transducer and a second ultrasound transducer, and wherein means b) operates said first ultrasound transducer to image said tissue ROI and operates said second ultrasound transducer to provide sufficient radiation energy to cause said release of said therapeutic agent.